Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12183421 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, Vandetanib;   Drug: Gemcitabine;   Drug: Placebo matching ZD6474

Indicates status has not been verified in more than two years